Cargando…
Use of (18)F-2-Fluorodeoxyglucose to Label Antibody Fragments for Immuno-Positron Emission Tomography of Pancreatic Cancer
[Image: see text] We generated (18)F-labeled antibody fragments for positron emission tomography (PET) imaging using a sortase-mediated reaction to install a trans-cyclooctene-functionalized short peptide onto proteins of interest, followed by reaction with a tetrazine-labeled-(18)F-2-deoxyfluoroglu...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2015
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4778250/ https://www.ncbi.nlm.nih.gov/pubmed/26955657 http://dx.doi.org/10.1021/acscentsci.5b00121 |
_version_ | 1782419431812497408 |
---|---|
author | Rashidian, Mohammad Keliher, Edmund J. Dougan, Michael Juras, Patrick K. Cavallari, Marco Wojtkiewicz, Gregory R. Jacobsen, Johanne T. Edens, Jerre G. Tas, Jeroen M. J. Victora, Gabriel Weissleder, Ralph Ploegh, Hidde |
author_facet | Rashidian, Mohammad Keliher, Edmund J. Dougan, Michael Juras, Patrick K. Cavallari, Marco Wojtkiewicz, Gregory R. Jacobsen, Johanne T. Edens, Jerre G. Tas, Jeroen M. J. Victora, Gabriel Weissleder, Ralph Ploegh, Hidde |
author_sort | Rashidian, Mohammad |
collection | PubMed |
description | [Image: see text] We generated (18)F-labeled antibody fragments for positron emission tomography (PET) imaging using a sortase-mediated reaction to install a trans-cyclooctene-functionalized short peptide onto proteins of interest, followed by reaction with a tetrazine-labeled-(18)F-2-deoxyfluoroglucose (FDG). The method is rapid, robust, and site-specific (radiochemical yields > 25%, not decay corrected). The availability of (18)F-2-deoxyfluoroglucose avoids the need for more complicated chemistries used to generate carbon–fluorine bonds. We demonstrate the utility of the method by detecting heterotopic pancreatic tumors in mice by PET, using anti-Class II MHC single domain antibodies. We correlate macroscopic PET images with microscopic two-photon visualization of the tumor. Our approach provides easy access to (18)F-labeled antibodies and their fragments at a level of molecular specificity that complements conventional (18)F-FDG imaging. |
format | Online Article Text |
id | pubmed-4778250 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | American Chemical Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-47782502016-05-09 Use of (18)F-2-Fluorodeoxyglucose to Label Antibody Fragments for Immuno-Positron Emission Tomography of Pancreatic Cancer Rashidian, Mohammad Keliher, Edmund J. Dougan, Michael Juras, Patrick K. Cavallari, Marco Wojtkiewicz, Gregory R. Jacobsen, Johanne T. Edens, Jerre G. Tas, Jeroen M. J. Victora, Gabriel Weissleder, Ralph Ploegh, Hidde ACS Cent Sci [Image: see text] We generated (18)F-labeled antibody fragments for positron emission tomography (PET) imaging using a sortase-mediated reaction to install a trans-cyclooctene-functionalized short peptide onto proteins of interest, followed by reaction with a tetrazine-labeled-(18)F-2-deoxyfluoroglucose (FDG). The method is rapid, robust, and site-specific (radiochemical yields > 25%, not decay corrected). The availability of (18)F-2-deoxyfluoroglucose avoids the need for more complicated chemistries used to generate carbon–fluorine bonds. We demonstrate the utility of the method by detecting heterotopic pancreatic tumors in mice by PET, using anti-Class II MHC single domain antibodies. We correlate macroscopic PET images with microscopic two-photon visualization of the tumor. Our approach provides easy access to (18)F-labeled antibodies and their fragments at a level of molecular specificity that complements conventional (18)F-FDG imaging. American Chemical Society 2015-06-03 2015-06-24 /pmc/articles/PMC4778250/ /pubmed/26955657 http://dx.doi.org/10.1021/acscentsci.5b00121 Text en Copyright © 2015 American Chemical Society This is an open access article published under an ACS AuthorChoice License (http://pubs.acs.org/page/policy/authorchoice_termsofuse.html) , which permits copying and redistribution of the article or any adaptations for non-commercial purposes. |
spellingShingle | Rashidian, Mohammad Keliher, Edmund J. Dougan, Michael Juras, Patrick K. Cavallari, Marco Wojtkiewicz, Gregory R. Jacobsen, Johanne T. Edens, Jerre G. Tas, Jeroen M. J. Victora, Gabriel Weissleder, Ralph Ploegh, Hidde Use of (18)F-2-Fluorodeoxyglucose to Label Antibody Fragments for Immuno-Positron Emission Tomography of Pancreatic Cancer |
title | Use of (18)F-2-Fluorodeoxyglucose
to Label Antibody Fragments for Immuno-Positron Emission Tomography
of Pancreatic Cancer |
title_full | Use of (18)F-2-Fluorodeoxyglucose
to Label Antibody Fragments for Immuno-Positron Emission Tomography
of Pancreatic Cancer |
title_fullStr | Use of (18)F-2-Fluorodeoxyglucose
to Label Antibody Fragments for Immuno-Positron Emission Tomography
of Pancreatic Cancer |
title_full_unstemmed | Use of (18)F-2-Fluorodeoxyglucose
to Label Antibody Fragments for Immuno-Positron Emission Tomography
of Pancreatic Cancer |
title_short | Use of (18)F-2-Fluorodeoxyglucose
to Label Antibody Fragments for Immuno-Positron Emission Tomography
of Pancreatic Cancer |
title_sort | use of (18)f-2-fluorodeoxyglucose
to label antibody fragments for immuno-positron emission tomography
of pancreatic cancer |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4778250/ https://www.ncbi.nlm.nih.gov/pubmed/26955657 http://dx.doi.org/10.1021/acscentsci.5b00121 |
work_keys_str_mv | AT rashidianmohammad useof18f2fluorodeoxyglucosetolabelantibodyfragmentsforimmunopositronemissiontomographyofpancreaticcancer AT keliheredmundj useof18f2fluorodeoxyglucosetolabelantibodyfragmentsforimmunopositronemissiontomographyofpancreaticcancer AT douganmichael useof18f2fluorodeoxyglucosetolabelantibodyfragmentsforimmunopositronemissiontomographyofpancreaticcancer AT juraspatrickk useof18f2fluorodeoxyglucosetolabelantibodyfragmentsforimmunopositronemissiontomographyofpancreaticcancer AT cavallarimarco useof18f2fluorodeoxyglucosetolabelantibodyfragmentsforimmunopositronemissiontomographyofpancreaticcancer AT wojtkiewiczgregoryr useof18f2fluorodeoxyglucosetolabelantibodyfragmentsforimmunopositronemissiontomographyofpancreaticcancer AT jacobsenjohannet useof18f2fluorodeoxyglucosetolabelantibodyfragmentsforimmunopositronemissiontomographyofpancreaticcancer AT edensjerreg useof18f2fluorodeoxyglucosetolabelantibodyfragmentsforimmunopositronemissiontomographyofpancreaticcancer AT tasjeroenmj useof18f2fluorodeoxyglucosetolabelantibodyfragmentsforimmunopositronemissiontomographyofpancreaticcancer AT victoragabriel useof18f2fluorodeoxyglucosetolabelantibodyfragmentsforimmunopositronemissiontomographyofpancreaticcancer AT weisslederralph useof18f2fluorodeoxyglucosetolabelantibodyfragmentsforimmunopositronemissiontomographyofpancreaticcancer AT ploeghhidde useof18f2fluorodeoxyglucosetolabelantibodyfragmentsforimmunopositronemissiontomographyofpancreaticcancer |